Hubungan Kalsium Ion Serum Dan Dosis Kumulatif Furosemide Dengan Nilai Ambang Pendengaran Pada Anak Sindrom Nefrotik
DAFTAR PUSTAKA
1. Kelsch RC, Sedman AB. Nephrotic Syndrome. Pediatrics in Review vol.14 N0.1.
from: http://pedsinreview.aappublications.org/atindonesia-overview
2. Trihono PP, Alatas H, Tambunan T, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Unit Kerja Koordinasi Nefrologi IDAI.
Cetakan Kedua. 2012.
3. Nabhan DAH. Hearing Status in Children with Nephrotic Syndrome (Thesis).
2014.
4. Boystown Research Registry. Ears and Kidneys: What’s the Connection.
Available from: http://www.oregon.gov/dhs/odhhs/pages/tadoc/hloss13.aspx
5. Suwento R, Zizlavsky S, Hendarmin H. Gangguan Pendengaran pada Bayi dan
Anak. Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorok Kepala & Leher.
Edisi Keenam. 2007. h. 31-42.
6. Wila WI. Penelitian Beberapa Aspek Klinis dan Patologi Anatomis Sindrom
Nefrotik Primer pada Anak di Indonesia. Disertasi, FKUI. Jakarta. 1992.
7. Gauvin DV, Abernathy MM, Tapp RL, Yoder JD, Dalton JA, Baird TJ. The failure
to detect drug-induced sensory lossin standard preclinical studies. Elseviere.
2015:1-22.
8. Verdel BM, Puijerbroek EP, Souverein PC, Leufkens HG, Egberts TC. Drugrelated nephrotoxic and ototoxic reactions: a link through a predictive
mechanistic commonality. Drug saf. 2008;31:877-84.
9. Lumpkin MA, Hudspeth AJ. Detection of Ca2+ entry throught mechanosensitive
channels localize the site of mechanoelectrical transduction in hair cells. Proc
Natl Acad Sci USA. 1995;92:10297-301.
10. Saha A, Gupta Y, Kapoor K, Dubey NK. Hearing Status in Children with
Frequently Relapsing and Steroid Resistant Nephrotic Syndrome. Pediatric
Nephrol. 2013; 28(3): 439-45.
11. Lane JC. Pediatric Nephrotic Syndrome. 2014. Available from:
http://emedicine.medscape.com/article/982920-overview
12. Cohen
EP.
Nephrotic
Syndrome.
2014.
Available
from:
http://emedicine.medscape.com/article/244631-overview
13. Tortora GJ, Derrickson BH. The Urinary System. Principles of Anatomy and
Physiology. Edisi 12. 2009. h. 1019-54.
14. Alatas H, Tambunan T, Trihono PP, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Unit Kerja Koordinasi Nefrologi IDAI.
2013.
15. Clark AG, Barrat TM. Steroid Responsive Nephrotic Syndrome. Lippincott
Williams &Wilkins. Pediatric Nephrology . Edisi Keempat. 1999:731-47.
50
Universitas Sumatera Utara
16. ISKDC. Nephrotic Syndrome in Children: Prediction of Histopathology from
Clinical and Laboratory Characteristics at Time of Diagnosis. Kidney Int.
1978;13:159-65.
17. ISKDC. The Primary Nephrotic Syndrome in Children. Identification of Patients
with Minimal Change Nephrotic Syndrome from Initial Response to Prednisone.
J Pediatr. 1981;98:561-4.
18. Haycock G. The Child with Idiopathic Nephrotic Syndrome. Clinical Pediatric
Nephrology. Edisi.3. New York: Oxford United Press. 2003:341-66.
19. Hodson EM. Pathophisiology and Management of Idiopathic Nephrotic
Syndrome in Children. Naskah Lengkap KONIKA 12. 2002.
20. Consensus Statement on Management and Audit Potential for Steroid
Responsive Nephrotic Syndrome. Report of a Workshop by the British
Association for Pediatric Nephrology and Research Unit, Royal College of
Physicians. Arch Dis Child. 1994;70:151-7.
21. Consensus Statement on Management of Steroid Sensitive Nephrotic
Syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics.
Indian Pediatrics. 2001;38:975-86.
22. Arbeitgemeinschaft für Pediatrische Nephrologie. Minimal Change Nephrotic
Syndrome: Long Prednisone Versus Standard Prednisone Therapy. Lancet.
1988;8:380-3.
23. Guillot P, Kim MS. Pulse Steroid Therapy does not Alter the Course of Focal
Segmental Glomerulosclerosis (abstract). J Am Soc Nephrol. 1993;4:276.
24. Tortora GJ, Derrickson BH. The Special Senses. Principles of Anatomy and
Physiology. Edisi 12. 2009. h. 628-35.
25. Trompeter RS. Immunosuppressive Therapy in Nephrotic Syndrome in Children.
Pediatr Nephrol. 1989;3:194.
26. Mudd
PA.
Ototoxicity.
2014.
Available
from:
http://emedicine.medscape.com/article/857679-overview
27. Kher K K, Schnaper H W, Makker S P. Clinical Pediatric Nephrology: Disorders
of mineral metabolism. UK: Informa Ltd, 2007. h. 38-60.
28. Hendarmin H, Suwento R. Gangguan pendengaran pada bayi dan anak. Dalam:
Soepardi EA, Iskandar N, penyunting. Buku Ajar Telinga-Hidung-Tenggorok
Kepala Leher. Jakarta: Balai Penerbit FKUI, 2001. h. 28-32.
29. Kennedy CR, Kimm L, Dees DC, Evans PIP, Hunter M, Lenton S, et al.
Otoacoustic emissions and auditory brainstem responses in the newborn. Arch
Dis Child 1991; 66:1124-9.
30. Harris F, Probst R. Otoacoustic emissions and audiometric outcomes. In:
Robinette MS, Glattke TJ, eds. Otoacoustic Emissions: Clinical Applications.
New York: Thieme Medical Publishers Inc, 1997
51
Universitas Sumatera Utara
31. Rundjan L, Amir I, Suwento R, Mangunatmadja I. Skrining gangguan
pendengaran pada neonatus risiko tinggi. Sari Pediatri, Vol. 6, No. 4, Maret
2005:149-54.
32. H Patel, M Feldman. Universal newborn hearing screening. canadian Paediatric
Society, community paediatrics committee. Paediatr child Health.
2011;16(5):301-05.
33. Deka RC. Auditory Brainstem Evoked Responses in Infants and Children. Indian
J Pediatr 1992;59:361-6.
34. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH
Perkiraan besar sampel. Dalam : Sastroasmoro S, Ismael S, penyunting. Dasardasar metodologi penelitian klinis. Edisi ke-3. Jakarta: CV Sagung Seto,
2008.h.302-30.
35. Orendorz-Frqczkowska K, Medynska A, Jablonka A, Gawron W. Hearing organ
function in children with nephrotic syndrome in course of primary
glomerulopathy. Otolaryngologia Polska. 2008. 12:182–7.
36. Ikeda K, Kusakari J, Kobayashi T, Saito Y. The effect of vitamin D deficiency on
the cochlear potentials and the perilymphatic ionized calcium concentration of
rats. Acta Otolaryngol Suppl. 2010; 435:64–72.
37. Beurg M, Nam JH, Chen Q, Fettiplace R. Calcium Balance and
Mechanotransduction in Rat Cochlear Hair Cells. J Neurophysiol. 2010; 104: 18–
34.
38. Giacomelloa M, De Marioa A, Primeranoa S, Brini M, Carafoli E. Hair cells,
plasma membrane Ca2+ ATPase and deafness. The International Journal of
Biochemistry & Cell Biology. 2012; 44: 679– 83.
39. Sewel WF. The relation between the endocochlear potential and spontaneous
activity in auditory nerve fibres of the cat. J.Physiol.1984; 347, pp.685-96.
40. Koch T, Gloddek B. Inhibition of adenylate-cyclasecoupled G protein complex
by ototoxic diuretics and cisplatinum in the inner ear of the guinea pig. Eur Arch
Otorhinolaryngol. 1999; 248:459–64.
41. Rybak LP, Whitworth C, Scott V. Furosemide ototoxicity is enhanced in
analbuminemic rats. Arch Otolaryngol Head Neck Surg. 1993; 119:758–61.
52
Universitas Sumatera Utara
1. Kelsch RC, Sedman AB. Nephrotic Syndrome. Pediatrics in Review vol.14 N0.1.
from: http://pedsinreview.aappublications.org/atindonesia-overview
2. Trihono PP, Alatas H, Tambunan T, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Unit Kerja Koordinasi Nefrologi IDAI.
Cetakan Kedua. 2012.
3. Nabhan DAH. Hearing Status in Children with Nephrotic Syndrome (Thesis).
2014.
4. Boystown Research Registry. Ears and Kidneys: What’s the Connection.
Available from: http://www.oregon.gov/dhs/odhhs/pages/tadoc/hloss13.aspx
5. Suwento R, Zizlavsky S, Hendarmin H. Gangguan Pendengaran pada Bayi dan
Anak. Buku Ajar Ilmu Kesehatan Telinga Hidung Tenggorok Kepala & Leher.
Edisi Keenam. 2007. h. 31-42.
6. Wila WI. Penelitian Beberapa Aspek Klinis dan Patologi Anatomis Sindrom
Nefrotik Primer pada Anak di Indonesia. Disertasi, FKUI. Jakarta. 1992.
7. Gauvin DV, Abernathy MM, Tapp RL, Yoder JD, Dalton JA, Baird TJ. The failure
to detect drug-induced sensory lossin standard preclinical studies. Elseviere.
2015:1-22.
8. Verdel BM, Puijerbroek EP, Souverein PC, Leufkens HG, Egberts TC. Drugrelated nephrotoxic and ototoxic reactions: a link through a predictive
mechanistic commonality. Drug saf. 2008;31:877-84.
9. Lumpkin MA, Hudspeth AJ. Detection of Ca2+ entry throught mechanosensitive
channels localize the site of mechanoelectrical transduction in hair cells. Proc
Natl Acad Sci USA. 1995;92:10297-301.
10. Saha A, Gupta Y, Kapoor K, Dubey NK. Hearing Status in Children with
Frequently Relapsing and Steroid Resistant Nephrotic Syndrome. Pediatric
Nephrol. 2013; 28(3): 439-45.
11. Lane JC. Pediatric Nephrotic Syndrome. 2014. Available from:
http://emedicine.medscape.com/article/982920-overview
12. Cohen
EP.
Nephrotic
Syndrome.
2014.
Available
from:
http://emedicine.medscape.com/article/244631-overview
13. Tortora GJ, Derrickson BH. The Urinary System. Principles of Anatomy and
Physiology. Edisi 12. 2009. h. 1019-54.
14. Alatas H, Tambunan T, Trihono PP, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Unit Kerja Koordinasi Nefrologi IDAI.
2013.
15. Clark AG, Barrat TM. Steroid Responsive Nephrotic Syndrome. Lippincott
Williams &Wilkins. Pediatric Nephrology . Edisi Keempat. 1999:731-47.
50
Universitas Sumatera Utara
16. ISKDC. Nephrotic Syndrome in Children: Prediction of Histopathology from
Clinical and Laboratory Characteristics at Time of Diagnosis. Kidney Int.
1978;13:159-65.
17. ISKDC. The Primary Nephrotic Syndrome in Children. Identification of Patients
with Minimal Change Nephrotic Syndrome from Initial Response to Prednisone.
J Pediatr. 1981;98:561-4.
18. Haycock G. The Child with Idiopathic Nephrotic Syndrome. Clinical Pediatric
Nephrology. Edisi.3. New York: Oxford United Press. 2003:341-66.
19. Hodson EM. Pathophisiology and Management of Idiopathic Nephrotic
Syndrome in Children. Naskah Lengkap KONIKA 12. 2002.
20. Consensus Statement on Management and Audit Potential for Steroid
Responsive Nephrotic Syndrome. Report of a Workshop by the British
Association for Pediatric Nephrology and Research Unit, Royal College of
Physicians. Arch Dis Child. 1994;70:151-7.
21. Consensus Statement on Management of Steroid Sensitive Nephrotic
Syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics.
Indian Pediatrics. 2001;38:975-86.
22. Arbeitgemeinschaft für Pediatrische Nephrologie. Minimal Change Nephrotic
Syndrome: Long Prednisone Versus Standard Prednisone Therapy. Lancet.
1988;8:380-3.
23. Guillot P, Kim MS. Pulse Steroid Therapy does not Alter the Course of Focal
Segmental Glomerulosclerosis (abstract). J Am Soc Nephrol. 1993;4:276.
24. Tortora GJ, Derrickson BH. The Special Senses. Principles of Anatomy and
Physiology. Edisi 12. 2009. h. 628-35.
25. Trompeter RS. Immunosuppressive Therapy in Nephrotic Syndrome in Children.
Pediatr Nephrol. 1989;3:194.
26. Mudd
PA.
Ototoxicity.
2014.
Available
from:
http://emedicine.medscape.com/article/857679-overview
27. Kher K K, Schnaper H W, Makker S P. Clinical Pediatric Nephrology: Disorders
of mineral metabolism. UK: Informa Ltd, 2007. h. 38-60.
28. Hendarmin H, Suwento R. Gangguan pendengaran pada bayi dan anak. Dalam:
Soepardi EA, Iskandar N, penyunting. Buku Ajar Telinga-Hidung-Tenggorok
Kepala Leher. Jakarta: Balai Penerbit FKUI, 2001. h. 28-32.
29. Kennedy CR, Kimm L, Dees DC, Evans PIP, Hunter M, Lenton S, et al.
Otoacoustic emissions and auditory brainstem responses in the newborn. Arch
Dis Child 1991; 66:1124-9.
30. Harris F, Probst R. Otoacoustic emissions and audiometric outcomes. In:
Robinette MS, Glattke TJ, eds. Otoacoustic Emissions: Clinical Applications.
New York: Thieme Medical Publishers Inc, 1997
51
Universitas Sumatera Utara
31. Rundjan L, Amir I, Suwento R, Mangunatmadja I. Skrining gangguan
pendengaran pada neonatus risiko tinggi. Sari Pediatri, Vol. 6, No. 4, Maret
2005:149-54.
32. H Patel, M Feldman. Universal newborn hearing screening. canadian Paediatric
Society, community paediatrics committee. Paediatr child Health.
2011;16(5):301-05.
33. Deka RC. Auditory Brainstem Evoked Responses in Infants and Children. Indian
J Pediatr 1992;59:361-6.
34. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH
Perkiraan besar sampel. Dalam : Sastroasmoro S, Ismael S, penyunting. Dasardasar metodologi penelitian klinis. Edisi ke-3. Jakarta: CV Sagung Seto,
2008.h.302-30.
35. Orendorz-Frqczkowska K, Medynska A, Jablonka A, Gawron W. Hearing organ
function in children with nephrotic syndrome in course of primary
glomerulopathy. Otolaryngologia Polska. 2008. 12:182–7.
36. Ikeda K, Kusakari J, Kobayashi T, Saito Y. The effect of vitamin D deficiency on
the cochlear potentials and the perilymphatic ionized calcium concentration of
rats. Acta Otolaryngol Suppl. 2010; 435:64–72.
37. Beurg M, Nam JH, Chen Q, Fettiplace R. Calcium Balance and
Mechanotransduction in Rat Cochlear Hair Cells. J Neurophysiol. 2010; 104: 18–
34.
38. Giacomelloa M, De Marioa A, Primeranoa S, Brini M, Carafoli E. Hair cells,
plasma membrane Ca2+ ATPase and deafness. The International Journal of
Biochemistry & Cell Biology. 2012; 44: 679– 83.
39. Sewel WF. The relation between the endocochlear potential and spontaneous
activity in auditory nerve fibres of the cat. J.Physiol.1984; 347, pp.685-96.
40. Koch T, Gloddek B. Inhibition of adenylate-cyclasecoupled G protein complex
by ototoxic diuretics and cisplatinum in the inner ear of the guinea pig. Eur Arch
Otorhinolaryngol. 1999; 248:459–64.
41. Rybak LP, Whitworth C, Scott V. Furosemide ototoxicity is enhanced in
analbuminemic rats. Arch Otolaryngol Head Neck Surg. 1993; 119:758–61.
52
Universitas Sumatera Utara